PPT1 and Alzheimer disease: Furthermore, a lack of change in PPT1 levels observed in the study by Henderson et al. following immunoblotting of human cortical samples from AD and various lysosomal storage diseases suggests that increased PPT1 levels not only reflect increased lipofuscin accumulation but may also be selective for ANCL (Henderson et al., 2016).